EU Funding For COVID-19 Drug & Diagnostic Research
Some Money Going To Work In Africa
Executive Summary
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.
You may also be interested in...
Industry And EU Bodies Get Together On COVID-19 Threat
European industry bodies have welcomed closer cooperation with EU institutions on addressing potential drug supply problems caused by the continuing spread of the coronavirus outbreak. Fresh funding has also been allocated for research into new vaccines, treatments and diagnostic tests.
Stark COVID-19 Drug Shortages Warning From Senior EU Regulator
The deputy head of the European Medicines Agency has outlined the steps the agency is taking to assess and address the possibility of drug shortages in Europe caused by the coronavirus outbreak, as the number of cases worldwide tops the 98,000 mark.
EU Call For Coronavirus Projects Sparks Big Pharma Interest
Europe’s Innovative Medicines Initiative is calling for R&D projects aimed at tackling the spread of COVID-19, saying that collaborative ventures have the potential to accelerate the development of therapeutics and diagnostics to tackle this and future coronavirus outbreaks.